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Abstract
Introduction and hypothesis Stress urinary incontinence
(SUI) is the most common type of urinary incontinence
(UI) in pregnant women and is known to have detrimental
effects on the quality of life in approximately 54.3 %. Preg-
nancy is the main risk factor for the development of SUI.
This review provides details of the pathophysiology leading
to SUI in pregnant women and SUI prevalence and treat-
ment during pregnancy.
Methods We conducted a PubMed search for English-
language and human-study articles registered from January
1990 to September 2012. This search was performed for
articles dealing with prevalence and treatment of SUI during
pregnancy. In the intervention studies, we included studies
that used a randomized controlled trial (RCT) design or
studies comparing a treatment intervention to no treatment.
Results A total of 534 articles were identified; 174 full-text
articles were reviewed, and 28 of them met eligibility crite-
ria and are reported on here. The mean prevalence of SUI
during pregnancy was 41 % (18.6–60 %) and increased with
gestational age. The increasing pressure of the growing
uterus and fetal weight on pelvic-floor muscles (PFM)
throughout pregnancy, together with pregnancy-related hor-
monal changes, may lead to reduced PFM strength as well
as their supportive and sphincteric function. These cause
mobility of the bladder neck and urethra, leading to urethral
sphincter incompetence. Pelvic floor muscle exercise
(PFME) is a safe and effective treatment for SUI during
pregnancy, without significant adverse effects.
Conclusions Understanding these issues can be useful for
health-care professionals when informing and counseling
pregnant women to help prevent SUI during pregnancy
and the postpartum period.
Keywords Stress urinary incontinence . Pregnancy .
Prevalence . Pathophysiology . Treatment . Review article
Introduction
Stress urinary incontinence (SUI), the complaint of invol-
untary loss of urine on effort or physical exertion or sneez-
ing or coughing [1], is the most common type of urinary
incontinence (UI) in pregnant women. It is known to have
detrimental effects on quality of life (QoL) in approximately
54.3 % of all pregnant women in four domains: physical
activity, travel, social relationships, and emotional health
[2]. Pregnant women with UI have statistically significant
lower QoL during pregnancy than those without UI [3], and
the QoL of incontinent pregnant women worsens with in-
creasing gestational age to term [4]. Pregnant women with
urgency (UUI) or mixed (MUI) incontinence had worse
QoL scores during pregnancy than those with SUI alone.
QoL scores on the physical, social, and emotional function-
ing domains were low, whereas scores on mobility and
embarrassment domains were higher, suggesting a minimal
restriction in lifestyle [5]. According to van Brummen et al.
[6], the bother of lower urinary tract symptoms (LUTS)
occurred most frequently at 36 weeks of pregnancy and
were still a bother at 1 year after pregnancy. Interestingly,
SUI occurred in the older maternal age groups, and the
presence of bothersome LUTS occurred at 12 weeks of
pregnancy, both of which were accounted to the predictive
factor of bothersome SUI at 1 year after delivery. According
to that study, cesarean section seemed to have a protective
effect on bothersome SUI at 1 year after delivery.
A related article can be found at doi:10.1007/s00192-012-2017-3.
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Mascarenhas et al. [3] reported that UI negatively affects
social relationships and particularly interferes with sexual
relationships. Dolan et al. [2] found that UI impinges on
sexual relationships. Although SUI severity increases with
pregnancy progression from the first to the third trimester
[7] and during 36 weeks of gestation, 16.9 % of pregnant
women report having moderate to greatly bothersome UUI
[6]. However, the QoL of pregnant women was found to be
mildly affected by UI [8]. This may be because UI symp-
toms were not severe [9]. Pregnant women tend to consider
this to be a common discomfort associated with pregnancy
and a consequence of childbirth in the postpartum period
[10]. Van de Pol et al. [4] found significantly higher rates of
depressive symptoms and SUI during pregnancy than after
childbirth. Another important impact of pregnancy-related
UI is an increased risk of permanent incontinence in the
postpartum period or later in life [11, 12]. Many studies
have reported that pregnant women who had UI during
pregnancy are at higher risk for postpartum UI than those
without UI during pregnancy [13–15].
Pregnancy and delivery-related factors are considered to
be the main risk factors for SUI development during preg-
nancy. The purpose of this review is to explain the patho-
physiology leading to SUI in pregnant women and SUI
prevalence and treatment during pregnancy. This informa-
tion can be useful for health-care professionals when
informing and counseling pregnant women in SUI preven-
tion during pregnancy and the postpartum period.
Materials and methods
This review was performed following the Preferred Report-
ing Items for Systematic Reviews and Meta-Analyses
(PRISMA) guidelines [16]. We conducted a PubMed search
for English-language and human-study articles registered
from January 1990 to September 2012 using the following
search terms: epidemiology, prevalence, urinary inconti-
nence, stress urinary incontinence, pregnancy, pregnant
women, pelvic-floor-muscle exercise, pelvic-floor-muscle
training, and conservative treatment Conference proceed-
ings and abstracts from the International Continence Society
annual meetings were also searched. Additional relevant
publications were selected from the reference lists of iden-
tified articles, and abstracts presented at international meet-
ing were also included. No language restriction was defined.
Abstracts and conventional reports were excluded. All
articles were screened by title and abstract by BS and NS.
Studies reporting on the prevalence of all UI that included
SUI, UUI, and MUI in pregnant women both primigravidae
and multigravidae were selected. Intervention studies related
to pelvic-floor-muscle exercises (PFME), pelvic-floor-
muscle training (PFMT), and other conservative treatments
to prevent and treat UI during pregnancy and the postnatal
period were included. In intervention studies, we included
studies that used a randomized controlled trial (RCT) design
or that compared a treatment intervention to no treatment.
Noncomparative studies (i.e., pre-post studies, case report,
case series) were excluded. A total of 534 publications in
PubMed were identified. Titles and abstracts were screened
for relevance and applicability, and 360 articles were ex-
cluded. The remaining 174 articles were screened in full
text. Of these, 26 articles were included: 18 of UI prevalence
and eight of UI treatment during pregnancy and the postna-
tal period met eligibility criteria as defined in Fig. 1.
The prevalence of urinary incontinence in pregnancy
The most common type of UI in pregnant women is SUI.
However, the true prevalence of SUI is still unknown. There
are many studies on the prevalence of SUI during pregnan-
cy, and results vary depending on study method and design,
such as definitions of UI, evaluation questionnaire, and
stage of pregnancy [12].
Most studies focused on European or Western counties.
Only a few studies determined SUI during pregnancy in
Asia, especially in Southeast Asia. Wesnes et al. [17] pre-
sented questionnaire data from the Norwegian Mother and
Child Cohort Study at the Norwegian Institute of Public
Health and found that the most common type of UI was
SUI in high prevalence in both nulliparous and multiparous
women, 31 % and 42 %, respectively. Morkved and Bø [18]
534 Citations from PubMed & Cochrane database 
174 Full text articles assessed
Total of 26 articles included:
- Prevalence of UI (n=18)
- PFME/ PFMT (n=8)
360 citations excluded
(after screening titles and/ or abstracts)
148 Articles excluded:
(because they did not meet the eligibility 
criteria)
Fig. 1 Selection process for the review of stress urinary incontinence
(SUI) prevalence and treatment during pregnancy
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from Norway found the prevalence of SUI during pregnancy
was 42 %. According to the same study, SUI was 38 %
8 weeks after delivery. Other studies from Europe (Table 1),
UK [19], Spain [20], Scotland [21], Germany [22], and
Denmark [23] found similarly high prevalence of SUI dur-
ing pregnancy.
A large population survey conducted in China [24] found
a little lower prevalence of UI compare with in Europe, but
it was still high among the pregnancy population: 26.7 % of
pregnant women presented with UI, including 18.6 % with
SUI, 4.3 % with MUI, and 2.0 % with UUI. In Taiwan, there
was some discrepancy. One study found a low incidence in
primiparous women: a prevalence of SUI, MUI, and UUI of
26.7 %, 6.1 %, and 4.7 %, respectively [25]. Another study
found a high prevalence: SUI, 46.1 % [26]. A study con-
ducted in Jordan also found the prevalence of SUI as high as
45 % and UUI at 35 % [27]. In India, the prevalence of SUI,
MUI, and UUI during pregnancy was 19.2 %, 3.8 %, and
2.9 %, respectively [28]. The highest reported prevalence of
SUI was in the USA. Thomason et al. [29] reported up to
60 %, whereas Raza-Khan et al. [30] found 70 % and 75 %
of UI prevalence in nulliparous and multiparous women,
respectively, and 32 % pure SUI. A high prevalence was
also reported South America [31]. Results reported from
Australia were comparable with those in the USA: 64 %
of women reported incontinence during pregnancy [32]. The
prevalence of SUI and MUI were more common during
pregnancy than was UUI alone: 36.9 %, 13.1 %, and
5.9 %, respectively [33]. In a multiethnic population in
Norway, Bø et al. [34] conducted their investigation in the
first trimester. They investigated the prevalence rate of SUI
at 28 weeks of gestation> and found the lowest prevalence
in women of African origin: 26 %. The prevalence in the
Middle East population was 36 %, slightly higher than in
women of African origin but lower than individual investi-
gation. A prevalence of 40 % and 43 % was found in East
and Southeast Asian women, which is higher than individ-
ual reports. The highest incidence was reported among
women of European or North American origin: 45 %. Al-
though the prevalence reported was different worldwide, the
concordant feature was the increasing prevalence with ges-
tational age [25, 26, 35]. The authors reported prevalence
was highest in third trimester, followed by in the second and
then first trimesters [25, 28, 36]. Only 13–19 % was
reported in the first trimester [25, 37]. The second trimester
was comparable at 19.2 %, but a significantly higher
prevalence was found in third trimester: 37.5 % [25]. UI
was higher with advance gestational age, as reported by
Wijma et al. [36], who found the incidence of UI
increased from 30 % at 28–32 weeks of gestation to
35 % at 36–38 weeks of gestation, which is similar to
that reported by Kerrebroeck et al. [38]. The number of
pregnant women with SUI varied according to this summary,
and the prevalence of SUI ranged from 18.6 % to 60 %, UUI
from 2 % to 35 %, and MUI from 3.8 % to 13.1 %, increasing
with gestational age. Many studies of the prevalence of UI are
shown in Table 1.
Anatomy and physiology of the lower urinary tract
during pregnancy
Normal anatomy and physiology of the lower urinary tract
plays an important role in the background of the knowledge
of the continence mechanism. Thorough knowledge of the
anatomy and physiology provides the concept of the UI. The
normal anatomy, the pelvic floor musculature complex, and
its normal physiology are beyond the scope of the review.
Pregnancy has significant effect on lower urinary tract
function. In uncomplicated pregnancy, micturition frequency
is influenced by the physiologic state of the bladder. Fre-
quency has been described as diurnal changes, which may
be up to seven times or more of normal, and slight nocturnal
changes of one or more times during the night. The inci-
dence is the same in both primigravidae and multigravidae
women [39]. The first trimester is the most common time of
onset. The uterine weight is the most important factor affect-
ing frequency throughout the pregnancy. Uterine weight not
only exerts pressure on the bladder but also irritates the
bladder. Normal bladder capacity in the first trimester is
410 ml [39]. In late pregnancy, descent of the presenting
part of fetus has an additional effect on bladder irritation.
Bladder capacity in the third trimester reduces to 272 ml in
conjunction with increased irritability of detrusor muscles
[39]. Alternative causes include nervous and hormonal influ-
ences. Indeed, the onset of frequency in late pregnancy is a
common symptom of engagement of the fetal head [39].
Approximately 80 % of pregnant women, both primigravi-
dae and multigravidae, experience increased micturition fre-
quency at some time during pregnancy [39]. Increased
frequency usually begins in early pregnancy but can occur
in the later stage; it disappears in mid pregnancy, which may
be due to the increase in bladder capacity to 460 ml in the
second trimester, and returns in the later weeks. [39]. Once
increased frequency has occurred, it is nearly always pro-
gressive and becomes increasingly worse until term [39].
Increased frequency during pregnancy results in polyuria
and is associated with increased fluid intake. However,
which is the cause and which the effect remains an unsolved
issue. Average daily excretion, output, and fluid intake are
highest in the second trimester and lowest in the third [39].
Uterine position is another issue that plays a significant
role. The impacted retrovert gravid uterus causes fluid reten-
tion because it interferes with the obliteration of the posterior
urethrovesical angle. It does not elevate the urethrovesical
junction in the pelvis, nor does it elongate the urethra [39].
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Pathophysiology of stress urinary incontinence
during pregnancy
PFM weakness causes bladder-neck and urethral mobility,
leading to urethral sphincter incompetence [40, 41]. When
the pregnant woman coughs, sneezes, laughs, or moves,
intra-abdominal pressure increases, and this pressure is
transmitted to the bladder. When pressure inside the bladder
is greater than urethral closure pressure, incorporated with
weakness of the urethral sphincter, SUI is the result. Preg-
nancy is one of the main risk factors for the development of
SUI in young women [42–44]. Studies in pregnant women
with SUI have found significantly decreased PFM strength
in incontinent pregnant women compared with continent
pregnant women [45]. Furthermore, there is a significantly
higher prevalence of SUI in pregnant women than in non-
pregnant women [46–48]. Pregnancy may also be associated
with reduced PFM strength, which can cause SUI. However,
the exact causes of pregnancy-related SUI remain unclear
[49]. Physiological changes during pregnancy may lead to
reduced PFM strength and SUI development in pregnant
women due to the following mechanism.
Trauma to the PFM due to maternal weight, the uterus,
and the fetus
Physiological weight gain during pregnancy may lead to
increased pressure on the PFM and bladder, which may result
in greater urethral mobility [50, 51]. Furthermore, excess
maternal weight gain may impair blood flow and innervations
to the bladder and urethra [52]. Several studies show the
association between obesity and SUI. Zhu et al. [24] reported
that the risk of SUI increased with increasing prenatal BMI
[odds ratio (OR = 1.037)]. Liang et al. [25] reported that
women with a prepregnancy BMI >30 kg/m2 were at in-
creased risk of developing SUI during pregnancy. Glazener
et al. [53] found that women with UI first occurring during
pregnancy had a BMI > 25 kg/m2 [OR 1.68, 95% confidence
interval (CI) 1.12–2.43]. Increased maternal weight correlated
with increased intra-abdominal pressure during urodynamic
assessments [54, 55]. In addition, increased BMI was not only
associated with UI but with pelvic organ prolapse (POP) as
well. Gyhagen et al [56] found that symptomatic POP in-
creased 3 % with each unit increase of BMI (OR 1.03; 95 %
CI 1.01–1.05). They also found that women with POP more
frequently had UI and UI> for > 10 years compared with
women without POP. Weakening of PFM is found more often
in women with POP [57]. Obesity or high BMI before preg-
nancy is a potentially modifiable risk factor for SUI; weight
reduction may be an effective treatment option [58]. Weight
loss by behavioral change can significantly improve SUI [58].
The growing uterus and fetus weigh solely on PFM,
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pregnancy and results in PFM weakness. Sphincter strength
and its supportive function of PFM are jeopardized [41, 47,
59]. Furthermore, multigravidity causes a decrease in PFM
strength at a rate of 22–35 % beginning at a gestational age
of 20 weeks and lasting until 6 weeks postpartum [40].
Hilde et al. [60], in a cross-sectional study of 300 nullipa-
rous women at 18–22 weeks’ gestational age showed that
continent pregnant women had significantly higher PFM
strength and endurance compared with incontinent pregnant
women (p=0.003 and p=0.01, respectively).
Prenatal issues and childbirth can damage the pudendal
nerve, caudal aspects of the levator ani muscle, fascial
pelvic organ supports, and the external and internal anal
sphincters [61, 62]. This damage reduces PFM strength
and may lead to increased bladder-neck and urethral mobil-
ity [63, 64] and cause mobility of the urethrovesical junction
[11]. Wijma et al. [65] found increased bladder-neck mobil-
ity from early pregnancy onward to near term. Jundt et al.
[66] found that pregnant women with SUI had more a
mobile bladder neck than continent pregnant women.
Collagen changes during pregnancy
Collagen changes included both tensile properties and num-
ber. Changes in tensile properties contribute to reduced
functional support of PFM, and reduced total collagen con-
tent may result in joint laxity and stretching of pelvic liga-
ments [67]. Several studies have reported a decrease in the
total collagen content in women with SUI [63, 68]. Keane et
al. [63] showed that nulliparous women with SUI had sig-
nificantly less collagen content in their tissues than did
continence pregnant women (p<0.0001). They also con-
cluded that the etiology of SUI in these pregnant women
appears due to both quantitative and qualitative reduction in
collagen.
Chen et al [69] showed the extracellular matrix (ECM)
component is related to increased elastase activity in vaginal
tissues obtained from SUI patients. In addition, the break-
down of collagen, smooth-muscle inhibition, and inflamma-
tory processes play an important role in contributing to SUI.
Lin et al. found the relevant genes that influence cellular
signaling pathways, including matrix metalloproteinases
(MMPs), regulator of G-protein signaling 2 (RGS2), and
SMAD2 [70]. Skorupski et al. also found more expression
of 1G/2G MMP-1 and the 5A/6A MMP-3 promoter single
nucleotide polymorphisms (SNPs) in women with POP than
in the population with a normal PFM [71]. Genetic and
environmental factors contribute to the occurrence of SUI
and POP. A study of twins by Altman et al [72] on SUI and
POP analyzed 3,376 monozygotic and 5,067 dizygotic fe-
male twins and found a greater similarity in outcomes in
monozygotic twins. In a study of nulliparous women, Dietz
et al. [73] demonstrated the heritability of bladder-neck
mobility. The systematic review by Lince et al. [74] found
a substantially greater likelihood of SUI in family members
with women with POP compares with women without POP,
indicating that genetic predisposition play an important role
in the development of POP.
Hormonal changes during pregnancy
Changes in relaxin and progesterone levels during pregnan-
cy may have a significant role in the development of SUI
[75].Relaxin, which plays an important role in maintaining
urinary continence during pregnancy [76], could stimulate
tissue growth in the lower urinary tract and increase urethral
pressure. There is a marked increase in relaxin concentration
to peak at a gestational age of 10–14 weeks and then
decrease to a stable level of approximately half the peak
value at the 17th–24th week of pregnancy, resulting in
decreased growth of the urethral epithelium [77, 78]. This
may lead to a decrease in urethral pressure [67]. As pregnant
women with SUI have lower urethral pressure than conti-
nent pregnant women [79], lower relaxin concentrations in
late pregnancy, therefore, correlate with a higher prevalence
of SUI at the second and third trimesters [76].
Progesterone increases during pregnancy from 24 ng/ml
at the 8th week to 150 ng/ml at the 36th week [80]. In-
creased progesterone may relax smooth muscles in the uri-
nary system [81], result in reduced ureter, bladder, and
urethral tone [82]. Values urethral pressure profile parame-
ters below the median value and defective transmission of
pressure over the urethra were observed in almost all preg-
nant women who experienced SUI during pregnancy. These
observations suggest that an inherent weakness of the ure-
thral sphincter mechanism plays a key role in the pathogen-
esis of SUI [80]. However, alterations in hormone levels
during pregnancy were not correlated with changes in ure-
thral pressure profile measurements [80].
The expansion of the uterus and fetal weight
Two major factors—expansion of the uterus and increment
increase in fetal weight with gestational age, especially at
the third trimester—influence the incontinence mechanism.
They put direct pressure on the bladder, which may lead to
changing the bladder-neck position [66] and reducing blad-
der capacity, contributing to bladder pressure that exceeds
urethral pressure [65, 83]. This results in urine leakage.
In summary, commonly encountered prenatal physiolog-
ical changes such as increasing pressure of the growing
uterus and fetal weight on PFM throughout pregnancy,
together with pregnancy-related hormonal changes in pro-
gesterone, estrogen, and relaxin, may lead to reduced
strength and supportive and sphincteric function of PFM.
PFM muscle weakness causes bladder-neck and urethral
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mobility, leading to urethral sphincter incompetence. Hence,
when intra-abdominal pressure is increased with coughing,
sneezing, laughing, or moving, the pressure inside the blad-
der becomes greater than the urethral closure pressure and
the urethral sphincter is not strong enough to maintain
urethral closure. Urinary leakage will be the result. In par-
ticular, SUI is common during pregnancy and puerperium.
After delivery, SUI symptoms resolve in the vast majority of
cases [84]. The healing process may take some time after the
delivery [85], but in a significant percentage of women, it
can persist in subsequent stages of life [84]. In primiparae
women, SUI symptoms tend to resolve within 3 month after
delivery [86].
The relevant literature reports that the prevalence of UI
decreases in the postpartum period [85, 87]. In general, UI
can affect 27.4 % of parous women for 6 months postpar-
tum, with only a small portion of women experiencing
spontaneous resolution [88]. Thomason et al. [29] found
that only 8 % of pregnant women who developed UI during
pregnancy had resolution, but in 47 % of those who had UI,
incontinence had not resolved at 6 months postpartum.
Glazener et al. [53] found that 13.5 % of primigravid wom-
en had SUI 3 months after delivery, whereas Wesnes et al.
[55] showed an SUI rate around 14 % at 6 months after
delivery. Groutz et al. [89] found that 1 year after the first
spontaneous vaginal delivery, 10.3 % of women had SUI.
Despite this clear association, the mechanism involved in
SUI remains unclear. Similarly, the pathophysiology of the
development of SUI during pregnancy is not clearly under-
stood. However, it has been suggested that it could be
caused by both hormonal and mechanical changes that occur
during this period [90, 91]. After pregnancy, most women
recover their prepregnancy hormonal levels, and pressure of
the enlarged uterus on the bladder and PFM resolves. Post-
natal remission of SUI may be explained by the resolution
of hormonal and metabolic changes associated with preg-
nancy and spontaneous healing of traumatic lesions due to
vaginal childbirth [92]. The compensation may be due to
PFM, which play a urethral support role, and it may be aided
by pelvic floor training [92]. Improvement in PFM strength
in women during the postpartum period showed that preg-
nancy, with its hormonal and mechanic effects, is a very
important risk factor for UI during pregnancy [87].
Treatment for stress urinary incontinence
during pregnancy
During pregnancy and postpartum, conservative therapy or
perineal rehabilitation by PFME is the first-line intervention to
treat SUI [35]. Pregnant women are often instructed to per-
form PFME to prevent the development and treat symptoms
of SUI during pregnancy [93]. Other treatments, whether
medical or surgical, must not be proposed at as the first
intervention during pregnancy or during the immediate post-
partum period [35].
Pelvic floor muscle exercise
PFME, the repetitively selective voluntary contraction and
relaxation of specific PFM [1], also known as Kegel exer-
cises, are the most popular method of treatment for SUI. In
the late 1940s, an American gynecologist named Arnold
Kegel first introduced this method for treating postpartum
UI and improving the function and tone of PFM following
childbirth. PFME have been successful because postpartum
women who have performed these exercises have reported
cure rates as high as 84 % and improvement rates as high as
100 % [94]. PFME is the most commonly recommended
conservative therapy for pregnant women with SUI. PFME
under the direction of a therapist (re-educator or midwife)
reduces the prevalence of UI in the short term compared
with simple advice about individual PFME [35]. Many
investigators have assessed the effectiveness of PFME, as
shown in Table 2.
PFME is used to strengthen the pelvic floor and periure-
thral muscles to improve the continence mechanism [44, 87,
95]. As a result, this method can either cure or relieve SUI
by reducing incontinence severity, including frequency and
volume of urine leakage [45, 96]. PFME prescribed during
pregnancy improves pregnancy UI and reduces the preva-
lence of UI in late pregnancy and early postpartum [35, 97].
Dinc et al. [87] found that pregnant women with PFME had
a significant decrease in UI episodes during pregnancy and
in the postpartum period. Undoubtedly, their PFM strength
increased to a larger extent. Sangsawang and Serisathien
[96] investigated the effects of a PFME on the severity of
SUI in 66 pregnant women who had SUI at gestational ages
of 20–30 weeks. After the PFME program, women in the
experimental group had significantly reduced frequency,
volume of urine leakage, and score of perceived SUI sever-
ity compared with those in the control group. They conclud-
ed that the 6-week PFME program was able to decrease
symptom severity in pregnant women with SUI. Sampselle
et al. [98] studied the effects of PFME on SUI and PFM
strength during pregnancy and postpartum in 72 primigravid
women with gestational ages of 20 weeks. This study sug-
gested that PFME can reduce the incidence of SUI at gesta-
tional ages of 35 weeks and at 6 weeks and 6 months
postpartum by significantly increasing PFM strength com-
pared with women who did not perform PFME. Morkved et
al. [99] found that pregnant women who performed PFME
reported 32 % UI at 36 weeks of gestational ages compared
to 48 % in the control group (p=.007). The number of
urinary leakage episodes at gestational age 36 weeks was
also significantly lower in the experimental group (p=.014).
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Furthermore, PFM strength was significantly higher in wom-
en with PFME at gestational age 36 weeks and 3 months after
delivery than in the control group (p=.008 and p=.048, re-
spectively). During late pregnancy and the postpartum period,
Ko et al. [100] found that women in the PFME group had
significantly lower total Urogenital Distress Inventory-6
(UDI-6) and Incontinence Impact Questionnaire-7 (IIQ-7)
scores; their self-report rate of UI was also less than in the
control group. This study concluded that PFME applied in
pregnancy was effective in treating and preventing UI during
pregnancy, and this effect may persist to postpartum period.
Stafne et al. [101] assessed the effect of a 12-week pelvic
floor muscle training (PFMT) to reduce self-reported UI and
fecal incontinence (FI) in late pregnancy in 855 women.
After the intervention, the authors found that fewer women
in the intervention group reported any weekly UI and FI
(11 % vs. 19 %, P=0.004 and 3 % vs. 5 %, P=0.18,
respectively). They indicated that pregnant women who
practice PFMT can prevent and treat UI in late pregnancy.
Glazener et al. [102] studied the effects of PFME on the
severity of UI at 12 months after delivery in 747 mothers
who still had UI 3 months postpartum. They found that
mothers in the intervention group had significantly less UI
and severe UI than the control group (59.9 % vs 69.0 %, p<
0.037 and 19.7 % vs 31.8 %, p<0.002, respectively). FI was
also less common in the intervention group than the control
group (4.4 % vs 10.5 %, p=0.012). The authors concluded
that PFMT provided by nurses seems to reduce UI and FI
that persists for 12 months postpartum. Reilly et al. [103]
studied the effects of antenatal PFME at a gestational age of
20 weeks until delivery for the prevention of postpartum
SUI in 268 primigravid women with bladder-neck mobility.
The authors suggested that antenatal PFME are effective in
reducing the risk of postpartum SUI in primigravid women
with bladder-neck mobility at 3 months postpartum. How-
ever, there were no changes in bladder-neck mobility and no
difference in PFM strength between groups after exercise.
PFME is a specific exercise for PFM and is different from
exercise of other muscles in the body. Thus, PFME requires a
strong commitment from women. Moreover, this form of
exercise requires dedication, endurance, and effort on the part
of women in order to result in effective SUI treatment [104].
Women without symptoms of SUI may not want to invest
their time in PFME [93]. Women with moderate to severe
symptoms of SUI may achieve more improvement in their
incontinence than women with mild symptoms. Alewijnse et
al. [105] found that women with severe symptoms were more
likely to maintain a higher adherence to PFME than women
with mild to moderate symptoms. Burns et al. [106] argued
that women with mild symptoms may not perceive their
incontinence as a serious problem, whereas patients with
severe symptoms recognized the incontinence as an ongoing
problem and view adherence to exercise as positive training to
affect a cure. Findings of that study are in accordance with the
study of Sangsawang and Serisathien [96], who found that
more than half (54.3 %) and nearly half (45.7 %) of pregnant
women in the intervention group had severe and moderate
symptoms of SUI, respectively, before participating in the
program. Thus, pregnant women may have perceived their
incontinence symptoms as a serious problem that could affect
their QoL. After completing the program at the sixth week,
100 % of pregnant women in the intervention group were able
to perform PFME every day during participated in the pro-
gram [96]. Women with SUI symptoms were encouraged to
perform this exercise continually, resulting in alleviation of
SUI symptoms and contributing to the continencemechanism.
Morkved et al. [99] found that 19 % of pregnant women had
some noncompliance (i.e., skipping classes) in the training
schedules of a 12-week antepartum PFME, which is a high
rate compared with compliance in drug trials of similar dura-
tion. Goode et al. [107] found that 11 % of women dropped
out of the 8-week PFME class because the treatment required
too much effort and time. In a 15-year follow-up, long-term
adherence to PFME was found to be low, with no difference
between intensive and home training programs [108].
In summary, PFME is the first-line conservative treatment
for women with SUI before consideration of other treatments
[97]. PFME is more a effective treatment for SUI during
pregnancy because it is a safe treatment without complica-
tions, inexpensive, simple to perform, does not require instru-
ments, and can be done anywhere and anytime [97, 109].
Conclusions
The most common type of UI in pregnant women is SUI. The
number of pregnant women with SUI in our literature review
was variable, with prevalence ranging from 18.6 % to 75 %
[16–32, 34] and increasing with gestational age. The increasing
pressure of the growing uterus and fetal weight on PFM
throughout pregnancy, together with pregnancy-related hor-
monal changes, may lead to reduced strength of the supportive
and sphincteric function of PFM. PFM weakness causes
bladder-neck and urethral mobility, thus leading to urethral
sphincter incompetence. Hence, when intra-abdominal pres-
sure increases, pressure inside the bladder becomes greater than
the urethral closure pressure, and the urethral sphincter is not
strong enough to close the urethra, resulting in urine leakage.
PFME is an effective treatment for SUI during pregnancy and
has no significant adverse effects. Continence can be improved
when incontinent pregnant women adequately perform PFME.
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